Consistent with the cancer-promoting roles of GnT-V, GnT-V-KO mice showed significantly reduced development and metastasis of polyoma virus middle T antigen–induced cancer (7), indicating that the inhibition of GnT-V activity is a potential new therapeutic option against cancer. The gene discussed is MGAT5; the disease is cancer.